CoChat

Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration

Open access
Scarfe, Lauren, Taylor, Arthur, Sharkey, Jack, Harwood, Rachel, Barrow, Michael, Comenge, Joan, Beeken, Lydia, Astley, Cai, Santeramo, Ilaria, Hutchinson, Claire, Ressel, Lorenzo, Smythe, Jon, Austin, Eric, Levy, Raphael, Rosseinsky, Matthew J., Adams, Dave J., Poptani, Harish, Park, Brian K., Murray, Patricia, Wilm, Bettina · 2018 · Stem Cell Research & Therapy
Cited by 103

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Cell-based regenerative medicine therapies are now frequently tested in clinical trials. In many conditions, cell therapies are administered systemically, but there is little understanding of their fate, and adverse events are often under-reported. Currently, it is only possible to assess safety and fate of cell therapies in preclinical studies, specifically by monitoring animals longitudinally using multi-modal imaging approaches. Here, using a suite of in vivo imaging modalities to explore the fate of a range of human and murine cells, we investigate how route of administration, cell type and host immune status affect the fate of administered cells. METHODS: We applied a unique imaging platform combining bioluminescence, optoacoustic and magnetic resonance imaging modalities to assess the safety of different human and murine cell types by following their biodistribution and persistence in mice following administration into the venous or arterial system. RESULTS: Longitudinal imaging analyses (i) suggested that the intra-arterial route may be more hazardous than intravenous administration for certain cell types, (ii) revealed that the potential of a mouse mesenchymal stem/stromal cell (MSC) line to form tumours depended on administration route and mouse strain and (iii) indicated that clinically tested human umbilical cord (hUC)-derived MSCs can transiently and unexpectedly proliferate when administered intravenously to mice. CONCLUSIONS: In order to perform an adequate safety assessment of potential cell-based therapies, a thorough understanding of cell biodistribution and fate post administration is required. The non-invasive imaging platform used here can expose not only the general organ distribution of these therapies, but also a detailed view of their presence within different organs and, importantly, tumourigenic potential. Our observation that the hUC-MSCs but not the human bone marrow (hBM)-derived MSCs persisted for a period in some animals suggests that therapies with these cells should proceed with caution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-018-1076-x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 103

Metadata

Authors
Scarfe, L., Taylor, A., Sharkey, J., Harwood, R., Barrow, M., Comenge, J., Beeken, L., Astley, C., Santeramo, I., Hutchinson, C., Ressel, L., Smythe, J., Austin, E., Levy, R., Rosseinsky, M. J., Adams, D. J., Poptani, H., Park, B. K., Murray, P., & Wilm, B.
Venue
Stem Cell Research & Therapy
Published
2018-11-28
Volume
9
Issue
1
Pages
332-332
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2902275158
Cited by
103
References
5
FWCI
4.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration. https://app.cochat.ai/papers/10.1186/s13287-018-1076-x
The paper
Scarfe, L., Taylor, A., Sharkey, J., Harwood, R., Barrow, M., Comenge, J., Beeken, L., Astley, C., Santeramo, I., Hutchinson, C., Ressel, L., Smythe, J., Austin, E., Levy, R., Rosseinsky, M. J., Adams, D. J., Poptani, H., Park, B. K., Murray, P., & Wilm, B. (2018). Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-018-1076-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.